The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1681
ISSUE1681
July 24, 2023
Inspire for Obstructive Sleep Apnea
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Inspire for Obstructive Sleep Apnea
July 24, 2023 (Issue: 1681)
The FDA recently expanded the eligibility criteria
(see Table 1) for treatment with the surgically
implanted hypoglossal nerve stimulation system
(Inspire Upper Airway Stimulation – Inspire Medical
Systems). The device has been advertised...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.